GILD
Gilead SciencesPrevious close
170.68
Change
+5.07 / +3.06%
P/E (TTM) ?
—
Market Cap
$213B
1M
+14.51%
S&P 500 −0.91% over same period
Volume / Avg Volume
11.4M / 6.2M
1.85× average
Latest earnings analysisFY2026 Q2Reported 2026-08-04
Gilead Q2 FY2026: revenue up 10.0% to $7.80 billion, but a $(8.45) loss per share
Gilead's base business grew 10.0% to $7.80 billion, but $11.18 billion of acquired IPR&D plus a $1.75 billion impairment turned the quarter into a $10.50 billion net loss. Read that as an accounting event about buying three companies, not a demand problem: HIV sales rose 12.0% and management raised its base-business sales forecast. The catch is a balance sheet that shed $7.43 billion of cash in six months.
Read the full analysis →Revenue$7.80BYoY +10.20%
EPS (non-GAAP)$-6.75Beatest. $-7.38
Next-quarter revenue guidance$30.25B ±0.5%YoY +287.70%
Next-day move−2.58%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-08-04 | $7.8B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-05-07 | $7.0B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-10 | $29.4B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-30 | $7.8B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-08-07 | $7.1B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-24 | $6.7B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
A 5-year P/E range needs a longer earnings record; not yet comparable
Last 4 quarters: $1.4B in buybacks + $4.1B in dividends, 2.57% of market cap combined
P/E (TTM)
—
P/B
17.9
P/S
7.0
Dividend Yield
3.98%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.8% on average on the first trading day after, rising 3 times
Most recent −2.58%
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 11 · $15.9MNet selling $15.9M
- 10-15Mercier JohannaChief Comm & Corp Aff OfficerSell$0.47M3,000 shares · Avg price 156.22
- 10-15Dickinson Andrew DChief Financial OfficerSell$0.47M3,000 shares · Avg price 156.22
- 10-01O'Day Daniel PatrickChairman & CEOSell$2.2M15,000 shares · 2 trades · Avg price 147.90
- 09-15Mercier JohannaChief Comm & Corp Aff OfficerSell$0.43M3,000 shares · 3 trades · Avg price 144.22
- 09-15Dickinson Andrew DChief Financial OfficerSell$0.44M3,000 shares · Avg price 145.29
- 09-01O'Day Daniel PatrickChairman & CEOSell$2.2M15,000 shares · 3 trades · Avg price 148.64
- 08-26WELTERS ANTHONYDirectorSell$2.7M18,000 shares · 4 trades · Avg price 148.62
- 08-20Bluestone JeffreyDirectorSell$0.73M5,000 shares · 5 trades · Avg price 145.02
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q3 | 8.30 | +6.8% | 81.1% | 2.43 | 1.94 |
| FY2026 Q2 | 7.80 | +10.2% | 79.8% | -10.50 | -8.45 |
| FY2026 Q1 | 6.96 | +4.4% | 79.2% | 2.02 | 1.61 |
| FY2025 Q4 | 7.93 | +4.7% | 79.5% | 2.18 | 1.75 |
| FY2025 Q3 | 7.77 | +3.0% | 79.8% | 3.05 | 2.43 |
| FY2025 Q2 | 7.08 | +1.8% | 78.8% | 1.96 | 1.56 |
| FY2025 Q1 | 6.67 | −0.3% | 76.9% | 1.32 | 1.04 |
| FY2024 Q4 | 7.57 | +6.4% | 79.1% | 1.78 | 1.43 |
| FY2024 Q3 | 7.55 | +7.0% | 79.1% | 1.25 | 1.00 |
| FY2024 Q2 | 6.95 | +5.4% | 77.8% | 1.61 | 1.29 |
| FY2024 Q1 | 6.69 | +5.3% | 76.8% | -4.17 | -3.34 |
| FY2023 Q4 | 7.11 | −3.7% | 70.6% | 1.43 | 1.14 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| ABT | 39.1 | +7.8% | 56.2% | +7.46% | Neutral |